Top line accelerating.
+8.3% YoY versus −2.2% prior. 3y CAGR +1.9%.
+8.3%We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $4.0B
Fundamentals as of 2026-04-03
The Question
Concerns — Envista Holdings Corp's 2.2% ROE is below sector median.
Financial story
Concerns — Envista Holdings Corp's 2.2% ROE and 0.81 debt-to-equity warrant a closer look at the underlying business.
Bottom line: NVST currently has no legendary investor models qualifying — see /stock/NVST/valuation for the per-model breakdown, but earns a D sector grade (41/100) in Healthcare. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
NVST's earnings calendar and history are tracked in the financials tab. Specific dates depend on company-published guidance.
NVST is in the Healthcare sector. Sector ranking and peer comparison are in the sector tab.
0 of 6 legendary investor models rate NVST a BUY. Fair value estimates and full investor breakdown are in the valuation tab.
Envista Holdings Corp's fair value depends on which model you trust. See the per-investor fair-value table in the valuation tab.
NVST trades at 59.1x earnings. Sector context and per-investor signals are in the valuation tab.
NVST and VKTX differ on P/E, ROE, and revenue growth. See the full NVST vs VKTX compare matrix
How does NVST compare?
See exactly where NVST ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingNVST sits at #88 in Healthcare with a D grade (41/100).
+8.3% YoY versus −2.2% prior. 3y CAGR +1.9%.
+8.3%Net margin 1.7% versus −44.6% prior (+46.3pp). Operating 8.3%.
1.7%P/E 56.3x — 1% below the 5y median of 56.9x. Forward 18.1x hints at EPS expansion next year.
56.3x